|
|
|
Insider
Information: |
Colella Samuel D |
Relationship: |
Director |
City: |
Santa Clara |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
203,276 |
|
Indirect Shares
|
2,453,199 |
|
|
Direct
Value |
$752,210 |
|
|
Indirect Value
|
$21,088,892 |
|
|
Total
Shares |
2,656,475 |
|
|
Total
Value |
$21,841,103 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
2
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
Percentage
Gain/Loss : |
130.6%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Genomic Health Inc |
GHDX |
Director |
2014-10-01 |
5,305 |
2014-10-01 |
54,348 |
Premium* |
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2010-01-26 |
36,862 |
2010-01-26 |
2,183,128 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2006-05-15 |
13,713 |
Premium* |
|
Insulet Corp |
PODD |
Former 10% Owner |
2007-05-14 |
0 |
2007-05-14 |
89,372 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2007-06-06 |
0 |
2008-07-21 |
13,247 |
Premium* |
|
Fluidigm Corp |
FLDM |
Director |
2020-03-11 |
161,109 |
2020-03-11 |
78,159 |
Premium* |
|
Veracyte, Inc. |
VCYT |
Director, 10% Owner |
2013-11-04 |
0 |
2013-11-04 |
21,232 |
Premium* |
|
Flexion Therapeutics Inc |
FLXN |
Director |
2021-11-19 |
0 |
2021-11-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
105 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FLDM |
Fluidigm Corp |
Director |
|
2017-05-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,326) |
40,197 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Director |
|
2021-01-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,180,675) |
5,871 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Director |
|
2021-11-19 |
4 |
D |
$8.50 |
$76,500 |
D/D |
(9,000) |
0 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Director |
|
2021-11-19 |
4 |
D |
$8.50 |
$12,644,294 |
I/I |
(1,487,564) |
0 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2016-03-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
550 |
19,123 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2016-12-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
600 |
43,523 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2017-12-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,800 |
51,245 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2011-02-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,254 |
|
- |
|
FLXN |
Flexion Therapeutics Inc |
Director |
|
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
105,780 |
|
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2011-02-15 |
4 |
OE |
$0.02 |
$165 |
I/I |
8,247 |
1,059,197 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2015-02-18 |
4 |
OE |
$16.00 |
$140,800 |
D/D |
8,800 |
28,473 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2015-02-19 |
4 |
OE |
$4.45 |
$461,961 |
D/D |
38,840 |
58,513 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2015-02-20 |
4 |
OE |
$4.45 |
$25,343 |
D/D |
5,700 |
25,373 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2017-07-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
45,197 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2017-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,848 |
53,045 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2017-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,848 |
59,093 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2018-05-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
79,923 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2019-06-20 |
4 |
OE |
$3.43 |
$144,762 |
D/D |
23,600 |
107,481 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-03-09 |
4 |
S |
$19.63 |
$1,177,800 |
I/I |
(60,000) |
86,808 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-03-10 |
4 |
S |
$19.21 |
$897,107 |
I/I |
(46,700) |
85,050 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-03 |
4 |
S |
$25.45 |
$873,444 |
I/I |
(34,320) |
37,552 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-17 |
4 |
S |
$33.52 |
$569,681 |
I/I |
(16,994) |
26,339 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-18 |
4 |
S |
$32.13 |
$298,789 |
I/I |
(9,300) |
20,202 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-11-19 |
4 |
S |
$26.97 |
$677,484 |
I/I |
(25,116) |
3,629 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-11-20 |
4 |
S |
$26.52 |
$145,846 |
I/I |
(5,500) |
0 |
0 |
- |
|
105 Records found
|
|
Page 4 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|